The start of a so-called rolling review formally begins an FDA evaluation of a closely watched drug that’s important to the biotech’s future, but faces questions about its sales potential.
Vertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain market, with the FDA ...
Higher doses of Narcan — or naloxone — do not affect the possibility of survival after an overdose. Be cautious.
The start of the opioid epidemic is ironically linked to a drug that was supposed to help people suffering from moderate to ...
Some argue a need for more potent — and pricier — overdose reversal drugs; others frame that effort as drugmakers peddling ...
Purdue Pharma has asked the federal Food and Drug Administration (FDA) to approve a new, auto-injectable form of one of its drugs to treat opioid overdoses. The Stamford-based biopharmaceutical ...
On average, Americans consume about 20 times the amount of prescription opioids as the rest of the world. It is no surprise ...
A group of 31 experts in genetics, addiction, psychiatry, and medical-device regulation sent letters to the FDA and Centers for Medicare and Medicaid Services, The Washington Post reported. The ...
Michigan must give its first responders additional tools to combat opioid overdoses amid the rise in fentanyl. That includes ...
A new additional drug in the fight against the opioid overdose crisis has slowly been making its way across the country and ...